LIVE

NBTX

Nanobiotix S.A.

NBTX

NASDAQ·Healthcare·Biotechnology·Mkt cap $2.0B

$38.40

▼ -2.74%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$4.79 - $57.14

P/E

—

Fwd P/E

-470.73

Beta

0.59

Div Yield

0.00%

Avg Vol

79.5K

Shares Out

—

Mkt Cap

$2.0B

Price action

Price chart

Up 734.7% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

No bull reasons captured for this rating yet.

▼

Bear Case

1 risk

  • Low volatility (beta 0.6).

Growth

Revenue decline expected

Value

Deep value opportunity - significant discount to sector peers

Momentum

Hot

+27.2% over 3m

Quality

Excellent

Mixed fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Sep 30, 2026

“
LATEST RECAP

Earnings recap unavailable for this period.

EPS surprise · last 4Q

No quarterly earnings data on file.

Next: Sep 30, 2026

Wall Street consensus

2 analysts · 50% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

1

50%

Hold

1

50%

Sell

0%

Median Price Target

$30.00

▼ -21.9% vs $38.40

Low $30.00
Median $30.00
High $30.00

Latest: UBS · $30.00 · May 1, 2026

1 analyst covering

View full analyst page →

vs Industry

How NBTX stacks vs Biotechnology

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.

Related

Peers & themes

Peers

No peer data available.

Themes

No themes assigned.